From: Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
ESO (n = 50)
LAN (n = 50)
Recurrent bleeding (%)#
2 (4%)
Hospital stay (days, s.e.m.)#*
3.9 (0.2)
1.8(0.3)
Volume of blood transfusion (ml, s.e.m.)
781 (145)
520 (101)
Surgery (%)
0 (0%)
Death (%)